Beatrice Langton-Webster

Cancer Targeted Technology, Llc

$11,636,102

Attributed

$11,636,102

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.9M · FY2010–25

$5M$3.8M$2.5M$1.3M$0

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$11,636,102 · 6

By mechanism

R44$9,036,102 · 4

N43$2,300,000 · 1

R43$300,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Cancer Targeted Technology, Llc

Same institution · by research overlap

Hunter Nicole Bomba$2,000,000

Others in their field

Top investigators on “Malignant Neoplasm Of Prostate”

David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
Walter John Curran · Thomas Jefferson University$61,298,085
Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
James J. Dignam · University Of Chicago$48,310,409
Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962

Research focus

Malignant Neoplasm Of ProstateRadiation TherapyTumorPositron-Emission TomographyClinical TrialsInnovationPharmaceutical PreparationsSafetyMalignant NeoplasmsMetastatic Neoplasm To The BoneUptakeAnimal ModelDoseCellsLabelSmall MoleculeCancer EtiologyBiological MarkersCancer DiagnosisFolh1 GeneProstate Cancer CellDesignAnimalsCessation Of Life